Expression of pEGFR and pAKT as response-predictive biomarkers for RAS wild-type patients to anti-EGFR monoclonal antibodies in metastatic colorectal cancers

Por Harlé, A, Salleron, J, Perkins, G, Pilati, C, Blons, H, Laurent-Puig, P, Merlin, J L
Publicado no Br J Cancer (2015)

P-061 Real-world experiences of use of aflibercept in patients with stage IV colorectal cancer in the North-West of England

Por Flaum, N., Kurup, R., Tong, D., Alchawaf, A., Lau, S., Harle, A., Hajri, R., Williamson, D., Papaxoinos, G., Mullamitha, S.
Publicado no Ann Oncol (2016)